Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The person must have signed an informed consent form agreeing to take part in the study
- A doctor must have confirmed a diagnosis of acute leukemia
- The person must be aged 26 years or older and under 80 years old
- The leukemia diagnosis must not yet have been treated
- The person must be hospitalised at Centre Henri Becquerel
- The person must be a member of, or covered by, a social security scheme
Who may not be able to join:
- People who are unable to understand the study or follow its requirements for any reason
- People whose acute leukemia has come back after previous treatment (relapse)
- People diagnosed with a specific type of leukemia classified as acute myeloid leukemia 3
- People who have had a cancer diagnosis in the 5 years before enrolling in the study
- People with alcohol or drug abuse issues
- People already enrolled in another treatment trial that does not allow participation in a trial measuring quality of life or psychological wellbeing
- People with a diagnosed psychiatric illness
- People who are under guardianship, curatorship, or another form of legal protection
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fabrice Jardin, Md PhD, Centre Henri Becquerel
Phone: +232082918
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Anxiety improvment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.